MY ACCOUNT | NEWSLETTER |

Boston clinic closes series A, plans to expand


Veterinary care provider since 2012, Boston Veterinary Clinic, has closed out a series A minority funding from investor Denali Growth Partners. With the new cash infusion, the clinic will add two new locations in the area, and move its current location to an upgraded facility among other improvements. 

"From our inception, Boston Veterinary Clinic has challenged the status quo of the veterinary medical experience,” said Paul Mataras, co-founder and chief executive officer of BVC. “We choose medical excellence and customized care, provided by an extraordinary team of professionals trained to provide a Fear Free experience over the one-size, impersonal approach of corporate medicine. We believe pets are your family and we want to be Boston's ‘other family doctor.’”

Boston Veterinary Clinic is a practice which has earned AAHA accreditation. Three years ago the facility also became a “fear free certified practice” meaning they engage in practices that aim to reduce animal fear while under care. "To be a Fear Free practice, we dedicate ourselves to the goal of reducing fear, anxiety, and stress for our patients and our clients. Less fear leads to better wellness care, faster diagnosis of problems and a higher quality, longer life for our patients," said Dr. Brian Bourquin, co-founder, chairman and chief veterinary officer. "We don't just talk about changing the veterinary experience, we've done it.”

The financing is expected to be used to initiate new veterinary services, to further invest in education for staff, and to invest in new technological advancements. 

"The Denali partnership provides BVC with more than capital. We get to work with a team of smart, energetic, thoughtful professionals who share our passion and our vision and will bring resources and relationships to help us achieve our goals." said Mataras. 


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top